The New Markers of Early Obesity-Related Organ and Metabolic Abnormalities
Authors:
- Agata Ziomber-LisiakAZAgata Ziomber-Lisiak
- Kaja PianaKPKaja Piana
- Beata OstachowiczBOBeata Ostachowicz
- Paweł WróbelPWPaweł Wróbel
- Paula KasprzykPKPaula Kasprzyk
- Jolanta Kaszuba-ZwoińskaJKJolanta Kaszuba-Zwoińska
- Agnieszka Baranowska-ChowaniecABAgnieszka Baranowska-Chowaniec
- Kajetan JuszczakKJKajetan Juszczak
- Magdalena Szczerbowska-BoruchowskaMSMagdalena Szczerbowska-Boruchowska
Open Access
- 3 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13437
Abstract
The objective of our study was to identify new markers related to excessive body adiposity and its early consequences. For this purpose we determined serum FGF-19 and FGF-21 concentrations in obese rats, whose role in the pathogenesis of obesity is not yet established. In addition, a total reflection X-ray fluorescence technique was applied to determine the elemental chemistry of certain tissues affected by obesity. Next, the new biochemical and molecular parameters were correlated with well-known obesity-related markers of metabolic abnormalities. Our obese rats were characterized by increased calorie consumption and body adiposity, hypercholesterolemia, elevated levels of liver enzymes and FGF-21, while the level of FGF-19 was reduced. Strong relationships between new hormones and established metabolic parameters were observed. Furthermore, we demonstrated that obesity had the greatest effect on elemental composition in the adipose tissue and liver and that rubidium (Rb) had the highest importance in distinguishing the studied groups of animals. Tissue Rb strongly correlated with both well-known and new markers of obesity. In conclusion, we confirmed serum FGF-19 and FGF-21 as useful new markers of obesity-related metabolic alternations and we robustly propose Rb as a novel indicator of excessive body adiposity and its early consequences. However, further investigations are encouraged to address this clinical issue.Keywords
Funding Information
- National Science Centre Poland (DEC-2013/09/B/NZ4/02539, DEC-2013/09/B/NZ4/02539)
- Ministry of Education and Science (Poland) (DEC-2013/09/B/NZ4/02539, DEC-2013/09/B/NZ4/02539)
This publication has 52 references indexed in Scilit:
- Dual actions of fibroblast growth factor 19 on lipid metabolismJournal of Lipid Research, 2013
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of ThiazolidinedionesCell, 2012
- A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescentsJournal of Pediatric Endocrinology and Metabolism, 2012
- The global obesity pandemic: shaped by global drivers and local environmentsThe Lancet, 2011
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α PathwayCell Metabolism, 2011
- Metabolic effects of obesity: A reviewWorld Journal of Diabetes, 2010
- The Effects of Metals as Endocrine DisruptorsJournal of Toxicology and Environmental Health, Part B, 2009
- Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21Diabetes, 2009
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005